Navigation Links
Marken Announces Appointment of Christopher O'Connell as New Chief Financial Officer
Date:8/9/2011

LONDON, Aug. 9, 2011 /PRNewswire/ -- Marken Ltd., a leading life sciences supply chain management organization, today announced the appointment of Christopher O'Connell as their new Chief Financial Officer (CFO) effective August 1, 2011.

Mr. O'Connell joins Marken with more than 20 years experience in the laboratory manufacturing and distribution services, construction and public accounting industries. He most recently worked for Thermo Fisher Scientific as Vice President of Finance for the Customer Channels Group, a multi-billion dollar, multi-national laboratory distribution and services group.  Thermo Fisher serves pharmaceutical and biotech companies, hospitals, clinical diagnostic labs, universities, research institutions and government agencies and has a portfolio of over 800,000 products.  

Mr. O'Connell also served Fisher in various roles which involved the development of the company's portfolio strategies, acquisitions and integration of new companies, management of shared service functions as well as having full income statement responsibilities across multiple business lines.  

"Chris' business insight, combined with his extensive financial leadership, acquisition integration expertise and pharmaceutical services and supplies familiarity at Thermo Fisher, make him an excellent addition to our executive leadership team. Our business expansion strategies will benefit enormously from Chris's background and leadership qualities." said Wes Wheeler, Chief Executive Officer of Marken.

Mr. O'Connell holds a Bachelor of Business Administration from Siena College and is a Certified Public Accountant.

About Marken

Founded in 1980, Marken is focused on supporting life science companies by managing their clinical supply chain and logistics through the entire clinical trial process. Marken integrates Depot and Logistics services into solutions that extend the reach of clinical trials to even the most remote treatment naïve geographies. As the leading logistics company managing global collection, transportation, storage and distribution of specimens and clinical trial supplies, Marken supports the clinical supply chain to over 6000 investigator sites in excess of 100 countries. Marken's team members and network of facilities bridge the distance between patients and the essential resources of life science companies.


'/>"/>
SOURCE Marken
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Marken Announces the Opening of a Directly Owned Clinical Trial Supply Depot in Singapore
2. Marken Rapidly Responds to Global Supply Chain Security Measures
3. Marken Unveils New Japan Office
4. MedShape Solutions Announces FDA 510(k) Clearance of Innovative Ankle Fusion Device
5. Lilly Announces Review of Data on Long-Term Raloxifene Treatment for Postmenopausal Osteoporosis Published in Current Medical Research & Opinion
6. Cepheid Announces Release of Updated Xpert BCR-ABL Monitor Test
7. Galil Medical Announces Reimbursement for Small Renal Cancer Cryoablation in Japan
8. Pharmasset Announces Two-for-One Forward Stock Split
9. Mindray Announces Second Quarter 2011 Financial Results
10. Boston Scientific Announces Favorable Court Ruling Dismissing Securities Fraud Case
11. K-V Pharmaceutical Company Announces the Completion of the Sale of Nesher Pharmaceuticals, Inc. its Generic Pharmaceutical Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)...  Las Vegas ophthalmology practice, Center For Sight, announced ... Dublin ), an implant that shunts ... intraocular pressure in patients with moderate to severe glaucoma. ... glaucoma that can lead to progressive optic nerve damage ... untreated. According to the National Eye Institute, ...
(Date:3/28/2017)... 2017 The U.S. Food and Drug ... adults with moderate-to-severe eczema (atopic dermatitis). Dupixent is ... adequately by topical therapies, or those for whom ... used with or without topical corticosteroids. ... approving new and innovative therapies for patients with ...
(Date:3/28/2017)... , March 28, 2017  "US Cancer Generics ... the various indicators and trend analysis related to ... in mainstream pharmaceutical market in US. The report ... the growth on cancer generics drugs in recent ... saving of billions of dollars for various stake ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... March 28, 2017 , ... ... and services, is proud to announce it has joined the National Association for ... the interests of chronically ill, disabled, and dying Americans of all ages and ...
(Date:3/28/2017)... ... March 28, 2017 , ... Via Oncology, ... the launch of a free, public-facing tool for analyzing the costs of various ... to provide comparative information to patients, providers, insurers and pharmaceutical companies about the ...
(Date:3/28/2017)... ... March 28, 2017 , ... Z-Medica, LLC, a ... Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) to equip ... in association with efforts by the American College of Surgeons, U.S. Department of ...
(Date:3/28/2017)... ... 28, 2017 , ... Usually, the impending arrival of warmer weather means the ... about a double chin, this means more anxiety than elation. The cosmetic dermatology experts ... people, a double chin is undesirable,” Dr. Goldman said, “but it seems doubly so ...
(Date:3/28/2017)... ... March 28, 2017 , ... Calibration, qualification, ... ensuring high-quality results and maintaining GMP and USP compliance. In a new webinar ... with GMP requirements " these requirements are explained. The challenge is to ...
Breaking Medicine News(10 mins):